YOKNEAM, ISRAEL--(Marketwire - October 28, 2008) - Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, announced today that Syneron will participate in the Oppenheimer Healthcare Conference on Monday, November 3, 2008 in New York and at the Barclays Capital Small and Mid-cap Healthcare Conference on Thursday, November 6, 2008, also in New York. Syneron CFO, Fabian Tenenbaum, will present on behalf of Syneron at both conferences. Mr. Tenenbaum will present at the Oppenheimer conference at noon ET on November 3rd and at the Barclays Capital conference at 10:00am on November 6th.
